search
Back to results

Noom Monitor for Binge Eating

Primary Purpose

Binge Eating Disorder

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
CBT-GSH with Noom Monitor
Sponsored by
Icahn School of Medicine at Mount Sinai
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Binge Eating Disorder focused on measuring Cognitive behavioral therapy guided self-help, Mobile Mental Health, Binge Eating, Cognitive Behavioral Therapy, Eating Disorder Treatment, Self-monitoring, Eating Disorders, Ecological Momentary Intervention

Eligibility Criteria

18 Years - 55 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Meets for DSM-5 BN or BED criteria
  • Between the ages of 18 and 55
  • Males and females
  • BMI greater than 18.5 and less than 40
  • Medical clearance in the case of reported purging or extreme exercise
  • Free of psychiatric medication for at least 2 weeks prior to study or on a stable dose of medication for 4 weeks
  • 1 year continuous enrollment in Kaiser Permanente Northwest health plan

Exclusion Criteria:

  • Has undergone bariatric surgery
  • Demonstrates need for higher level of care (e.g., very low weight (<18.5))
  • Current comorbid substance dependence, bipolar or psychotic illness
  • Current suicidal ideation
  • Previously received Enhance Cognitive behavioral therapy or Cognitive behavioral therapy-guided self help
  • Previously read Overcoming Binge Eating by Christopher Fairburn
  • Purging and/or laxative use more than 2x a day on average over the last month.

Sites / Locations

  • Kaiser Permanente Center for Health Research

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

Treatment as Usual

CBT-GSH with Noom Monitor

Arm Description

The control group for the RCT will be a "usual care" condition in which participants are free to seek any assistance for their ED during the study period.

Participation will include 12 weeks of guided cognitive-behavioral therapy- guided self help (CBT-GSH) with an MA-level health coach or nutritionist from the KPNW health plan. Patients will use a self-help book, Overcoming Binge Eating (2013) by Christopher Fairburn. The first session will last 60 minutes, and each subsequent session lasts 20-25 minutes. The first four sessions are weekly, with the subsequent four twice monthly. Self-monitoring will be conducted through Noom Monitor and individuals will receive a specialized set of instructions on how to use the monitor. Therapists will also be asked to check feedback report on clients before each session.

Outcomes

Primary Outcome Measures

Objective Binge Days
Objective Binge Days - Objective binge days item of Eating Disorder Examination Scale version 16 (EDE-Q V6) - Frequency of days with objective binge episodes
Objective Binge Days
Objective Binge Days - Objective binge days item of EDE-Q V6 - Frequency of days with objective binge episodes
Objective Binge Days
Objective Binge Days - Objective binge days item of EDE-Q V6 - Frequency of days with objective binge episodes
Objective Binge Days
Objective Binge Days - Objective binge days item of EDE-Q V6 - Frequency of days with objective binge episodes
Objective Binge Days
Objective Binge Days - Objective binge days item of EDE-Q V6 - Frequency of days with objective binge episodes
Objective Binge Days
Objective Binge Days - Objective binge days item of EDE-Q V6 - Frequency of days with objective binge episodes
Sum of Compensatory Episodes
Sum of days where vomiting, laxative, or compulsive exercise occurs - sum of 3 items on EDE-Q v6
Sum of Compensatory Episodes
Sum of days where vomiting, laxative, or compulsive exercise occurs - sum of 3 items on EDE-Q v6
Sum of Compensatory Episodes
Sum of days where vomiting, laxative, or compulsive exercise occurs - sum of 3 items on EDE-Q v6
Sum of Compensatory Episodes
Sum of days where vomiting, laxative, or compulsive exercise occurs - sum of 3 items on EDE-Q v6
Sum of Compensatory Episodes
Sum of days where vomiting, laxative, or compulsive exercise occurs - sum of 3 items on EDE-Q v6
Sum of Compensatory Episodes
Sum of days where vomiting, laxative, or compulsive exercise occurs -sum of 3 items on EDE-Q v6

Secondary Outcome Measures

Clinical Impairment Assessment
Full scale from 0-48, with higher score indicating more impairment
Clinical Impairment Assessment
Full scale from 0-48, with higher score indicating more impairment
Clinical Impairment Assessment
Full scale from 0-48, with higher score indicating more impairment
Clinical Impairment Assessment
Full scale from 0-48, with higher score indicating more impairment
Clinical Impairment Assessment
Full scale from 0-48, with higher score indicating more impairment
Clinical Impairment Assessment
Full scale from 0-48, with higher score indicating more impairment
Personal Health Questionnaire
Full scale from 0-24, with higher score indicating more depression
Personal Health Questionnaire
Full scale from 0-24, with higher score indicating more depression
Personal Health Questionnaire
Full scale from 0-24, with higher score indicating more depression
Personal Health Questionnaire
Full scale from 0-24, with higher score indicating more depression
Personal Health Questionnaire
Full scale from 0-24, with higher score indicating more depression
Personal Health Questionnaire
Full scale from 0-24, with higher score indicating more depression
Quality of Life Scale
Full scale from 16-112, with higher score indicating better health outcomes
Quality of Life Scale
Full scale from 16-112, with higher score indicating better health outcomes
Quality of Life Scale
Full scale from 16-112, with higher score indicating better health outcomes
Quality of Life Scale
Full scale from 16-112, with higher score indicating better health outcomes
Quality of Life Scale
Full scale from 16-112, with higher score indicating better health outcomes
Quality of Life Scale
Full scale from 16-112, with higher score indicating better health outcomes
Eating Concern Subscale
Eating concern subscale of the EDE-QV6 from 0-6 with higher score indicating worse health outcomes
Eating Concern Subscale
Eating concern subscale of the EDE-QV6 from 0-6 with higher score indicating worse health outcomes
Eating Concern Subscale
Eating concern subscale of the EDE-Q v6 from 0-6 with higher score indicating worse health outcomes
Eating Concern Subscale
Eating concern subscale of the EDE-Q v6 from 0-6 with higher score indicating worse health outcomes
Eating Concern Subscale
Eating concern subscale of the EDE-Q v6 from 0-6 with higher score indicating worse health outcomes
Eating Concern Subscale
Eating concern subscale of the EDE-Q v6 from 0-6 with higher score indicating worse health outcomes
Dietary Restraint Subscale
Dietary Restraint Subscale of the EDE-Q v6 from 0-6, with higher score indicating worse health outcomes
Dietary Restraint Subscale
Dietary Restraint Subscale of the EDE-Q v6 from 0-6, with higher score indicating worse health outcomes
Dietary Restraint Subscale
Dietary Restraint Subscale of the EDE-Q v6 from 0-6, with higher score indicating worse health outcomes
Dietary Restraint Subscale
Dietary Restraint Subscale of the EDE-Q v6 from 0-6, with higher score indicating worse health outcomes
Dietary Restraint Subscale
Dietary Restraint Subscale of the EDE-Q v6 from 0-6, with higher score indicating worse health outcomes
Dietary Restraint Subscale
Dietary Restraint Subscale of the EDE-Q v6 from 0-6, with higher score indicating worse health outcomes
Shape Concern Subscale
Shape Concern Subscale of the EDE-Q v6 from 0-6, with higher score indicating worse health outcomes
Shape Concern Subscale
Shape Concern Subscale of the EDE-Q v6 from 0-6, with higher score indicating worse health outcomes
Shape Concern Subscale
Shape Concern Subscale of the EDE-Q v6 from 0-6, with higher score indicating worse health outcomes
Shape Concern Subscale
Shape Concern Subscale of the EDE-Q v6 from 0-6, with higher score indicating worse health outcomes
Shape Concern Subscale
Shape Concern Subscale of the EDE-Q v6 from 0-6, with higher score indicating worse health outcomes
Shape Concern Subscale
Shape Concern Subscale of the EDE-Q v6 from 0-6, with higher score indicating worse health outcomes
Weight Concern Subscale
Weight Concern Subscale of the EDE-Q v6 from 0-6, with higher score indicating worse health outcomes
Weight Concern Subscale
Weight Concern Subscale of the EDE-Q v6 from 0-6, with higher score indicating worse health outcomes
Weight Concern Subscale
Weight Concern Subscale of the EDE-Q v6 from 0-6, with higher score indicating worse health outcomes
Weight Concern Subscale
Weight Concern Subscale of the EDE-Q v6 from 0-6, with higher score indicating worse health outcomes
Weight Concern Subscale
Weight Concern Subscale of the EDE-Q v6 from 0-6, with higher score indicating worse health outcomes
Weight Concern Subscale
Weight Concern Subscale of the EDE-Q v6 from 0-6, with higher score indicating worse health outcomes
Global Eating Disorder Subscale
Global Eating Disorder Subscale of the EDE-Q v6 from 0-6, with higher score indicating worse health outcomes
Global Eating Disorder Subscale
Global Eating Disorder Subscale of the EDE-Q v6 from 0-6, with higher score indicating worse health outcomes
Global Eating Disorder Subscale
Global Eating Disorder Subscale of the EDE-Q v6 from 0-6, with higher score indicating worse health outcomes
Global Eating Disorder Subscale
Global Eating Disorder Subscale of the EDE-Q v6 from 0-6, with higher score indicating worse health outcomes
Global Eating Disorder Subscale
Global Eating Disorder Subscale of the EDE-Q v6 from 0-6, with higher score indicating worse health outcomes
Global Eating Disorder Subscale
Global Eating Disorder Subscale of the EDE-Q v6 from 0-6, with higher score indicating worse health outcomes

Full Information

First Posted
September 17, 2015
Last Updated
September 25, 2019
Sponsor
Icahn School of Medicine at Mount Sinai
Collaborators
Noom Inc., Kaiser Permanente
search

1. Study Identification

Unique Protocol Identification Number
NCT02555553
Brief Title
Noom Monitor for Binge Eating
Official Title
Noom Monitor for Binge Eating
Study Type
Interventional

2. Study Status

Record Verification Date
September 2019
Overall Recruitment Status
Completed
Study Start Date
April 2016 (Actual)
Primary Completion Date
May 1, 2018 (Actual)
Study Completion Date
May 1, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Icahn School of Medicine at Mount Sinai
Collaborators
Noom Inc., Kaiser Permanente

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of the proposed Phase II STTR study is to test the primary efficacy of a novel mobile app, 'Noom Monitor,' in a large population of binge eaters in the Kaiser Permanente health care system relative to a well-established treatment as usual (TAU) control condition. Noom Monitor facilitates the delivery of CBT-GSH by utilizing a patient interface that increases adherence and provides between-session reminders of CBT-GSH principles. In addition, the Noom Monitor includes a therapist interface with weekly feedback to the provider about patient progress. This application has several primary objectives, including: (1) testing the real-world effectiveness of the Noom Monitor in a clinical setting, and (2) establishing a database of training materials for Noom Monitor. The knowledge gained from the current study will contribute to our understanding of the role of new emerging mobile technologies in augmenting existing treatments.
Detailed Description
Binge eating is a core maladaptive behavior characteristic of several forms of eating pathology, including bulimia nervosa (BN) and binge eating disorder (BED). These chronic conditions affect approximately 5% of the population, and cause significant psychosocial and physical impairment. However, a number of barriers prevent the implementation of effective treatments, including poor treatment adherence, a paucity of specialized therapists, and high rates of drop out. The guided self-help version of cognitive-behavior therapy (CBT-GSH) is a brief 8-session highly scalable treatment to reduce binge eating. Moreover, CBT-GSH is a cost-effective empirically supported treatment that has been demonstrated to reduce total health care costs. Although CBT-GSH for BN and BED is effective, few individuals receive these treatments and the majority of other available treatments do not meet adequate standards for care for eating disorders. There are a number of reasons for why this is the case, but an important concern about CBT-GSH is participant burden. The primary CBT-GSH intervention is self-monitoring, a uniquely effective technique for reducing binge eating episodes; however, traditional self-monitoring is time-intensive and cumbersome because of its paper-and-pencil format. In addition, other behavioral strategies utilized in CBT-GSH (e.g., the development of regular eating) require a high degree of participant engagement outside of session. Novel technologies, such as those available with smartphones, offer potentially important means for reducing participant burden in the delivery of CBT-GSH. The purpose of the proposed is to test the primary efficacy of a novel mobile app, 'Noom Monitor' in a large population of binge eaters relative to a well-established treatment as usual (TAU) control condition. The investigative team developed these products via phase I study (R41-MH096435) to facilitate delivery of a cognitive-behavior therapy version of Guided Self-Help. The efficacy and product development aims of this proposal will be used to support the commercial launch of Noom Monitor, a smartphone platform.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Binge Eating Disorder
Keywords
Cognitive behavioral therapy guided self-help, Mobile Mental Health, Binge Eating, Cognitive Behavioral Therapy, Eating Disorder Treatment, Self-monitoring, Eating Disorders, Ecological Momentary Intervention

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
225 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Treatment as Usual
Arm Type
No Intervention
Arm Description
The control group for the RCT will be a "usual care" condition in which participants are free to seek any assistance for their ED during the study period.
Arm Title
CBT-GSH with Noom Monitor
Arm Type
Experimental
Arm Description
Participation will include 12 weeks of guided cognitive-behavioral therapy- guided self help (CBT-GSH) with an MA-level health coach or nutritionist from the KPNW health plan. Patients will use a self-help book, Overcoming Binge Eating (2013) by Christopher Fairburn. The first session will last 60 minutes, and each subsequent session lasts 20-25 minutes. The first four sessions are weekly, with the subsequent four twice monthly. Self-monitoring will be conducted through Noom Monitor and individuals will receive a specialized set of instructions on how to use the monitor. Therapists will also be asked to check feedback report on clients before each session.
Intervention Type
Behavioral
Intervention Name(s)
CBT-GSH with Noom Monitor
Intervention Description
This intervention is cognitive behavioral treatment with a smartphone application
Primary Outcome Measure Information:
Title
Objective Binge Days
Description
Objective Binge Days - Objective binge days item of Eating Disorder Examination Scale version 16 (EDE-Q V6) - Frequency of days with objective binge episodes
Time Frame
At 0 week
Title
Objective Binge Days
Description
Objective Binge Days - Objective binge days item of EDE-Q V6 - Frequency of days with objective binge episodes
Time Frame
At 4 weeks
Title
Objective Binge Days
Description
Objective Binge Days - Objective binge days item of EDE-Q V6 - Frequency of days with objective binge episodes
Time Frame
At 8 weeks
Title
Objective Binge Days
Description
Objective Binge Days - Objective binge days item of EDE-Q V6 - Frequency of days with objective binge episodes
Time Frame
At 12 weeks
Title
Objective Binge Days
Description
Objective Binge Days - Objective binge days item of EDE-Q V6 - Frequency of days with objective binge episodes
Time Frame
At 26 weeks
Title
Objective Binge Days
Description
Objective Binge Days - Objective binge days item of EDE-Q V6 - Frequency of days with objective binge episodes
Time Frame
At 52 weeks
Title
Sum of Compensatory Episodes
Description
Sum of days where vomiting, laxative, or compulsive exercise occurs - sum of 3 items on EDE-Q v6
Time Frame
At 0 week
Title
Sum of Compensatory Episodes
Description
Sum of days where vomiting, laxative, or compulsive exercise occurs - sum of 3 items on EDE-Q v6
Time Frame
At 4 weeks
Title
Sum of Compensatory Episodes
Description
Sum of days where vomiting, laxative, or compulsive exercise occurs - sum of 3 items on EDE-Q v6
Time Frame
At 8 weeks
Title
Sum of Compensatory Episodes
Description
Sum of days where vomiting, laxative, or compulsive exercise occurs - sum of 3 items on EDE-Q v6
Time Frame
At 12 weeks
Title
Sum of Compensatory Episodes
Description
Sum of days where vomiting, laxative, or compulsive exercise occurs - sum of 3 items on EDE-Q v6
Time Frame
At 26 weeks
Title
Sum of Compensatory Episodes
Description
Sum of days where vomiting, laxative, or compulsive exercise occurs -sum of 3 items on EDE-Q v6
Time Frame
At 52 weeks
Secondary Outcome Measure Information:
Title
Clinical Impairment Assessment
Description
Full scale from 0-48, with higher score indicating more impairment
Time Frame
At 0 week
Title
Clinical Impairment Assessment
Description
Full scale from 0-48, with higher score indicating more impairment
Time Frame
At 4 weeks
Title
Clinical Impairment Assessment
Description
Full scale from 0-48, with higher score indicating more impairment
Time Frame
At 8 weeks
Title
Clinical Impairment Assessment
Description
Full scale from 0-48, with higher score indicating more impairment
Time Frame
At 12 weeks
Title
Clinical Impairment Assessment
Description
Full scale from 0-48, with higher score indicating more impairment
Time Frame
At 26 weeks
Title
Clinical Impairment Assessment
Description
Full scale from 0-48, with higher score indicating more impairment
Time Frame
At 52 weeks
Title
Personal Health Questionnaire
Description
Full scale from 0-24, with higher score indicating more depression
Time Frame
At 0 weeks
Title
Personal Health Questionnaire
Description
Full scale from 0-24, with higher score indicating more depression
Time Frame
At 4 weeks
Title
Personal Health Questionnaire
Description
Full scale from 0-24, with higher score indicating more depression
Time Frame
At 8 weeks
Title
Personal Health Questionnaire
Description
Full scale from 0-24, with higher score indicating more depression
Time Frame
At 12 weeks
Title
Personal Health Questionnaire
Description
Full scale from 0-24, with higher score indicating more depression
Time Frame
At 26 weeks
Title
Personal Health Questionnaire
Description
Full scale from 0-24, with higher score indicating more depression
Time Frame
At 52 weeks
Title
Quality of Life Scale
Description
Full scale from 16-112, with higher score indicating better health outcomes
Time Frame
At 0 week
Title
Quality of Life Scale
Description
Full scale from 16-112, with higher score indicating better health outcomes
Time Frame
At 4 weeks
Title
Quality of Life Scale
Description
Full scale from 16-112, with higher score indicating better health outcomes
Time Frame
At 8 weeks
Title
Quality of Life Scale
Description
Full scale from 16-112, with higher score indicating better health outcomes
Time Frame
At 12 weeks
Title
Quality of Life Scale
Description
Full scale from 16-112, with higher score indicating better health outcomes
Time Frame
At 26 weeks
Title
Quality of Life Scale
Description
Full scale from 16-112, with higher score indicating better health outcomes
Time Frame
At 52 weeks
Title
Eating Concern Subscale
Description
Eating concern subscale of the EDE-QV6 from 0-6 with higher score indicating worse health outcomes
Time Frame
At 0 week
Title
Eating Concern Subscale
Description
Eating concern subscale of the EDE-QV6 from 0-6 with higher score indicating worse health outcomes
Time Frame
At 4 weeks
Title
Eating Concern Subscale
Description
Eating concern subscale of the EDE-Q v6 from 0-6 with higher score indicating worse health outcomes
Time Frame
At 8 weeks
Title
Eating Concern Subscale
Description
Eating concern subscale of the EDE-Q v6 from 0-6 with higher score indicating worse health outcomes
Time Frame
At 12 weeks
Title
Eating Concern Subscale
Description
Eating concern subscale of the EDE-Q v6 from 0-6 with higher score indicating worse health outcomes
Time Frame
At 26 weeks
Title
Eating Concern Subscale
Description
Eating concern subscale of the EDE-Q v6 from 0-6 with higher score indicating worse health outcomes
Time Frame
At 52 weeks
Title
Dietary Restraint Subscale
Description
Dietary Restraint Subscale of the EDE-Q v6 from 0-6, with higher score indicating worse health outcomes
Time Frame
At 0 week
Title
Dietary Restraint Subscale
Description
Dietary Restraint Subscale of the EDE-Q v6 from 0-6, with higher score indicating worse health outcomes
Time Frame
At 4 weeks
Title
Dietary Restraint Subscale
Description
Dietary Restraint Subscale of the EDE-Q v6 from 0-6, with higher score indicating worse health outcomes
Time Frame
At 8 weeks
Title
Dietary Restraint Subscale
Description
Dietary Restraint Subscale of the EDE-Q v6 from 0-6, with higher score indicating worse health outcomes
Time Frame
At 12 weeks
Title
Dietary Restraint Subscale
Description
Dietary Restraint Subscale of the EDE-Q v6 from 0-6, with higher score indicating worse health outcomes
Time Frame
At 26 weeks
Title
Dietary Restraint Subscale
Description
Dietary Restraint Subscale of the EDE-Q v6 from 0-6, with higher score indicating worse health outcomes
Time Frame
At 52 weeks
Title
Shape Concern Subscale
Description
Shape Concern Subscale of the EDE-Q v6 from 0-6, with higher score indicating worse health outcomes
Time Frame
At 0 week
Title
Shape Concern Subscale
Description
Shape Concern Subscale of the EDE-Q v6 from 0-6, with higher score indicating worse health outcomes
Time Frame
At 4 weeks
Title
Shape Concern Subscale
Description
Shape Concern Subscale of the EDE-Q v6 from 0-6, with higher score indicating worse health outcomes
Time Frame
At 8 weeks
Title
Shape Concern Subscale
Description
Shape Concern Subscale of the EDE-Q v6 from 0-6, with higher score indicating worse health outcomes
Time Frame
At 12 weeks
Title
Shape Concern Subscale
Description
Shape Concern Subscale of the EDE-Q v6 from 0-6, with higher score indicating worse health outcomes
Time Frame
At 26 weeks
Title
Shape Concern Subscale
Description
Shape Concern Subscale of the EDE-Q v6 from 0-6, with higher score indicating worse health outcomes
Time Frame
At 52 weeks
Title
Weight Concern Subscale
Description
Weight Concern Subscale of the EDE-Q v6 from 0-6, with higher score indicating worse health outcomes
Time Frame
At 0 Week
Title
Weight Concern Subscale
Description
Weight Concern Subscale of the EDE-Q v6 from 0-6, with higher score indicating worse health outcomes
Time Frame
At 4 Weeks
Title
Weight Concern Subscale
Description
Weight Concern Subscale of the EDE-Q v6 from 0-6, with higher score indicating worse health outcomes
Time Frame
At 8 Weeks
Title
Weight Concern Subscale
Description
Weight Concern Subscale of the EDE-Q v6 from 0-6, with higher score indicating worse health outcomes
Time Frame
At 12 Weeks
Title
Weight Concern Subscale
Description
Weight Concern Subscale of the EDE-Q v6 from 0-6, with higher score indicating worse health outcomes
Time Frame
At 26 Weeks
Title
Weight Concern Subscale
Description
Weight Concern Subscale of the EDE-Q v6 from 0-6, with higher score indicating worse health outcomes
Time Frame
At 52 Weeks
Title
Global Eating Disorder Subscale
Description
Global Eating Disorder Subscale of the EDE-Q v6 from 0-6, with higher score indicating worse health outcomes
Time Frame
At 0 week
Title
Global Eating Disorder Subscale
Description
Global Eating Disorder Subscale of the EDE-Q v6 from 0-6, with higher score indicating worse health outcomes
Time Frame
At 4 weeks
Title
Global Eating Disorder Subscale
Description
Global Eating Disorder Subscale of the EDE-Q v6 from 0-6, with higher score indicating worse health outcomes
Time Frame
At 8 weeks
Title
Global Eating Disorder Subscale
Description
Global Eating Disorder Subscale of the EDE-Q v6 from 0-6, with higher score indicating worse health outcomes
Time Frame
At 12 weeks
Title
Global Eating Disorder Subscale
Description
Global Eating Disorder Subscale of the EDE-Q v6 from 0-6, with higher score indicating worse health outcomes
Time Frame
At 26 weeks
Title
Global Eating Disorder Subscale
Description
Global Eating Disorder Subscale of the EDE-Q v6 from 0-6, with higher score indicating worse health outcomes
Time Frame
At 52 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
55 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Meets for DSM-5 BN or BED criteria Between the ages of 18 and 55 Males and females BMI greater than 18.5 and less than 40 Medical clearance in the case of reported purging or extreme exercise Free of psychiatric medication for at least 2 weeks prior to study or on a stable dose of medication for 4 weeks 1 year continuous enrollment in Kaiser Permanente Northwest health plan Exclusion Criteria: Has undergone bariatric surgery Demonstrates need for higher level of care (e.g., very low weight (<18.5)) Current comorbid substance dependence, bipolar or psychotic illness Current suicidal ideation Previously received Enhance Cognitive behavioral therapy or Cognitive behavioral therapy-guided self help Previously read Overcoming Binge Eating by Christopher Fairburn Purging and/or laxative use more than 2x a day on average over the last month.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Tom Hildebrandt, PsyD
Organizational Affiliation
Icahn School of Medicine at Mount Sinai
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Lynn DeBar, PhD
Organizational Affiliation
Kaiser Permanente
Official's Role
Principal Investigator
Facility Information:
Facility Name
Kaiser Permanente Center for Health Research
City
Portland
State/Province
Oregon
ZIP/Postal Code
97227-1098
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
32008396
Citation
Hildebrandt T, Michaeledes A, Mayhew M, Greif R, Sysko R, Toro-Ramos T, DeBar L. Randomized Controlled Trial Comparing Health Coach-Delivered Smartphone-Guided Self-Help With Standard Care for Adults With Binge Eating. Am J Psychiatry. 2020 Feb 1;177(2):134-142. doi: 10.1176/appi.ajp.2019.19020184.
Results Reference
derived

Learn more about this trial

Noom Monitor for Binge Eating

We'll reach out to this number within 24 hrs